MicroRNA deregulation in human thyroid papillary carcinomas

P Pallante1, R Visone, M Ferracin

  • 1Dipartimento di Biologia e Patologia Cellulare e Molecolare, c/o Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, via Pansini, 5, 80131 Naples, Italy.

Insights

MicroRNAs (miRNAs) are key regulators in cell processes and cancer. This study identified specific miRNA signatures, including increased miR-221, -222, and -181b, in thyroid papillary carcinomas, suggesting their role in thyroid cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating fundamental cellular processes.
  • Aberrant miRNA expression is implicated in various human cancers, including thyroid cancer.
  • Thyroid papillary carcinoma (PTC) is the most common type of thyroid cancer.

Purpose of the Study:

  • To analyze the genome-wide miRNA expression profile in human thyroid papillary carcinomas (PTCs).
  • To identify specific miRNAs differentially expressed between PTCs and normal thyroid tissues.
  • To investigate the role of specific miRNAs in thyroid carcinogenesis.

Main Methods:

  • Genome-wide miRNA expression profiling using a microarray (miRNACHIP microarray).
  • Validation of miRNA expression using northern blot and quantitative RT-PCR.
  • Analysis of miRNA expression in fine needle aspiration biopsies and animal models.

Main Results:

  • A distinct miRNA expression profile was identified in PTCs compared to normal thyroid tissues.
  • Significant overexpression of miR-221, miR-222, and miR-181b was observed in PTCs.
  • Overexpression of these miRNAs was also detected in thyroid nodules, cell lines, and mouse models of thyroid carcinogenesis.

Conclusions:

  • An miRNA signature associated with PTCs was identified.
  • MiRNA deregulation, particularly the overexpression of miR-221, -222, and -181b, plays a critical role in thyroid cell transformation and carcinogenesis.
  • These findings suggest potential diagnostic and therapeutic implications for miRNAs in thyroid cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...